Neuroimaging abnormalities, neurocognitive function, and fatigue in patients with hepatitis C

Neurology: Neuroimmunology and NeuroInflammation

Volumn 2, Issue 1, 2015, Pages

  Thames, April D ^a   Castellon, Steven A ^a,b   Singer, Elyse J ^a   Nagarajan, Rajakumar ^a   Sarma, Manoj K ^a   Smith, Jason ^b   Thaler, Nicholas S ^a   Truong, Jonathan Hien ^b   Schonfeld, Daniel ^b   Thomas, M Albert ^b   Hinkin, Charles H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYLASPARTIC ACID;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS C; CLINICAL ASSESSMENT; COGNITION; COGNITION ASSESSMENT; COGNITIVE FUNCTION TEST; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS STRIATUM; DIFFUSION TENSOR IMAGING; FATIGUE; FEMALE; FRACTIONAL ANISOTROPY; FUNCTIONAL NEUROIMAGING; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCIPITOFRONTAL FASCICULUS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; VELOCITY;

EID: 85014713560     PISSN: None     EISSN: 23327812     Source Type: Journal    
DOI: 10.1212/NXI.0000000000000059     Document Type: Article

References (36)

1. Centers for Disease Control and Prevention: Hepatitis C Information for Health Professionals (2014, July). Available at: http://www.cdc.gov/hepatitis/HCV/index.htm. Accessed January 2, 2014.
2. Fletcher NF, Yang JP, Farquhar MJ, et al. Hepatitis C virus infection of neuroepithelioma cell lines. Gastroenterology 2010;139:1365-1374.
3. Laskus T, Radkowski M, Bednarska A, et al. Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol 2002;76:10064-10068.
4. Hilsabeck RC, Hassanein TI, Carlson MD, Ziegler EA, Perry W. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc 2003;9:847-854.
5. Hinkin CH, Castellon SA, Levine AJ, Barclay TR, Singer EJ. Neurocognition in individuals co-infected with HIV and hepatitis C. J Addict Dis 2008;27:11-17.
6. Forton DM, Thomas HC, Murphy CA, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002;35:433-439.
7. Grover VP, Pavese N, Koh SB, et al. Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation. J Viral Hepat 2012;19:89-96.
8. Weissenborn K, Krause J, Bokemeyer M, et al. Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 2004;41:845-851.
9. Bladowska J, Zimny A, Knysz B, et al. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study. J Hepatol 2013; 59:651-657.
10. Bladowska J, Zimny A, Kołtowska A, et al. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation. Eur J Radiol 2013;82:686-692.
11. Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD. Evidence for a cerebral effect of the hepatitis C virus. Lancet 2001;358:38-39.
12. Forton DM, Hamilton G, Allsop JM, et al. Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study. J Hepatol 2008;49: 316-322.
13. Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 2002;35:440-446.
14. Ryan EL, Morgello S, Isaacs K, Naseer M, Gerits P. Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology 2004;62:957-962.
15. Martin EM, Novak RM, Fendrich M, et al. Stroop performance in drug users classified by HIV and hepatitis C virus serostatus. J Int Neuropsychol Soc 2004;10:298-300.
16. Senzolo M, Schiff S, D'Aloiso CM, et al. Neuropsychological alterations in hepatitis C infection: the role of inflammation. World J Gastroenterol 2011;17:3369-3374.
17. McAndrews MP, Farcnik K, Carlen P, et al. Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology 2005;41:801-808.
18. Wechsler D. Wechsler Adult Intelligence Scale-Third Edition (WAIS-III), 3rd ed. San Antonio, TX: The Psychological Corporation; 1997.
19. Gronwall DM. Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills 1977;44:367-373.
20. Partington JE, Leiter RG. Partington's pathway test. Psychol Serv Cent Bull 1949;1:9-20.
21. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643-662.
22. Brandt J, Benedict RHB. Hopkins Verbal Learning Test, Revised (HVLT-R). Odessa, FL: Psychological Assessment Resources; 1999.
23. Benedict RHB. Brief Visuospatial Memory Test - Revised (BVMT-R). Odessa, FL: Psychological Assessment Resources, Inc.; 1997.
24. Benton AL, Hamsher K, Sivan AB. Controlled oral word association test (COWAT). Multilingual Aphasia Examination, 3rd ed. Iowa City, IA: AJA Associates; 1983.
25. Matthews CJ, Kløve H. Instruction Manual for the Adult Neuropsychology Test Battery. Madison, WI: University of Wisconsin Medical School; 1964.
26. Lee KA, Hicks G, Nino-Murcia G. Validity and reliability of a scale to assess fatigue. Psychiatry Res 1991;36:291-298.
27. Chan T, Vese L. Active contours without edges. IEEE Trans Image Process 2001;10:266-277.
28. Gongvatana A, Cohen RA, Correia S, et al. Clinical contributors to cerebral white matter integrity in HIV-infected individuals. J Neurovirol 2011;17:477-486.
29. Stebbins GT, Smith CA, Bartt RE, et al. HIV-associated alterations in normal-appearing white matter: a voxel-wise diffusion tensor imaging study. J Acquir Immune Defic Syndr 2007;46:564-573.
30. Smith SA, Levante TO, Meier BH, Ernst RR. Computer simulations in magnetic resonance. An object-oriented programming approach. J Magn Reson Ser A 1994;106:75-105.
31. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stast Soc Series B 1995;54:289-300.
32. Douaud G, Behrens TE, Poupon C, et al. In vivo evidence for the selective subcortical degeneration in Huntington's disease. Neuroimage 2009;46:958-966.
33. Osuka S, Matsushita A, Ishikawa E, et al. Elevated diffusion anisotropy in gray matter and the degree of brain compression. J Neurosurg 2012;117:363-371.
34. Catani M, Dell'acqua F, Vergani F, et al. Short frontal lobe connections of the human brain. Cortex 2012;48: 273-291.
35. Nagarajan R, Sarma MK, Thames AD, Castellon SA, Hinkin CH, Thomas MA. 2D MR spectroscopy combined with prior-knowledge fitting is sensitive to HCV-associated cerebral metabolic abnormalities. Int J Hepatol 2012;2012:179365.
36. Thames AD, Foley JM, Wright MJ, et al. Basal ganglia structures differentially contribute to verbal fluency: evidence from Human Immunodeficiency Virus (HIV)-infected adults. Neuropsychologia 2012;50:390-395.